FOLFOX and FLOX regimens for the adjuvant treatment of resected stage II and III colon cancer.
作者： Saima Sharif , Michael J O'Connell , Greg Yothers , Samia Lopa , Norman Wolmark
DOI: 10.1080/07357900802132550
关键词:
摘要: The MOSAIC trial showed that the use of adjuvant oxaliplatin and an infusional regimen 5-FU/LV in treatment stage II/III colon cancer improved disease-free survival (DFS). NSABP's C-07 evaluated addition to a weekly Roswell Park bolus found similar improvement DFS. benefit appears be independent used. This paper reviews efficacy toxicities these two regimens is meant serve as guide for clinical practice.
informahealthcare.com参考文章(18)
A de Gramont, J F Bosset, C Milan, P Rougier, O Bouché, P L Etienne, F Morvan, C Louvet, T Guillot, E François, L Bedenne, Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study. Journal of Clinical Oncology. ,vol. 15, pp. 808- 815 ,(1997) , 10.1200/JCO.1997.15.2.808
N Wolmark, H Rockette, B Fisher, D L Wickerham, C Redmond, E R Fisher, J Jones, E P Mamounas, L Ore, N J Petrelli, The Benefit of Leucovorin-Modulated Fluorouracil as Postoperative Adjuvant Therapy for Primary Colon Cancer: Results From National Surgical Adjuvant Breast and Bowel Project Protocol C-03 Journal of Clinical Oncology. ,vol. 11, pp. 1879- 1887 ,(1993) , 10.1200/JCO.1993.11.10.1879
J Philip Kuebler, Linda Colangelo, Michael J O'Connell, Roy E Smith, Greg Yothers, Mirsada Begovic, Bridget Robinson, Thomas E Seay, Norman Wolmark, None, Severe enteropathy among patients with stage II/III colon cancer treated on a randomized trial of bolus 5-fluorouracil/leucovorin plus or minus oxaliplatin: a prospective analysis. Cancer. ,vol. 110, pp. 1945- 1950 ,(2007) , 10.1002/CNCR.23013
Eric Van Cutsem, Marc Peeters, Salvatore Siena, Yves Humblet, Alain Hendlisz, Bart Neyns, Jean-Luc Canon, Jean-Luc Van Laethem, Joan Maurel, Gary Richardson, Michael Wolf, Rafael G. Amado, Open-Label Phase III Trial of Panitumumab Plus Best Supportive Care Compared With Best Supportive Care Alone in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer Journal of Clinical Oncology. ,vol. 25, pp. 1658- 1664 ,(2007) , 10.1200/JCO.2006.08.1620
J Philip Kuebler, H Samuel Wieand, Michael J O'Connell, Roy E Smith, Linda H Colangelo, Greg Yothers, Nicholas J Petrelli, Michael P Findlay, Thomas E Seay, James N Atkins, John L Zapas, J Wendall Goodwin, Louis Fehrenbacher, Ramesh K Ramanathan, Barbara A Conley, Patrick J Flynn, Gamini Soori, Lauren K Colman, Edward A Levine, Keith S Lanier, Norman Wolmark, None, Oxaliplatin Combined With Weekly Bolus Fluorouracil and Leucovorin As Surgical Adjuvant Chemotherapy for Stage II and III Colon Cancer: Results From NSABP C-07 Journal of Clinical Oncology. ,vol. 25, pp. 2198- 2204 ,(2007) , 10.1200/JCO.2006.08.2974
Stephanie R Land, Jacek A Kopec, Reena S Cecchini, Patricia A Ganz, H Samuel Wieand, Linda H Colangelo, Kate Murphy, J Philip Kuebler, Thomas E Seay, Burton M Needles, James D Bearden III, Lauren K Colman, Keith S Lanier, Eduardo R Pajon Jr, David Cella, Roy E Smith, Michael J O'Connell, Joseph P Costantino, Norman Wolmark, None, Neurotoxicity From Oxaliplatin Combined With Weekly Bolus Fluorouracil and Leucovorin As Surgical Adjuvant Chemotherapy for Stage II and III Colon Cancer: NSABP C-07 Journal of Clinical Oncology. ,vol. 25, pp. 2205- 2211 ,(2007) , 10.1200/JCO.2006.08.6652
A. de Gramont, A. Figer, M. Seymour, M. Homerin, A. Hmissi, J. Cassidy, C. Boni, H. Cortes-Funes, A. Cervantes, G. Freyer, D. Papamichael, N. Le Bail, C. Louvet, D. Hendler, F. de Braud, C. Wilson, F. Morvan, A. Bonetti, Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer Journal of Clinical Oncology. ,vol. 18, pp. 2938- 2947 ,(2000) , 10.1200/JCO.2000.18.16.2938
Richard M. Goldberg, Daniel J. Sargent, Roscoe F. Morton, Charles S. Fuchs, Ramesh K. Ramanathan, Stephen K. Williamson, Brian P. Findlay, Henry C. Pitot, Steven R. Alberts, A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer Journal of Clinical Oncology. ,vol. 22, pp. 23- 30 ,(2004) , 10.1200/JCO.2004.09.046
JY Douillard, D Cunningham, AD Roth, M Navarro, RD James, P Karasek, P Jandik, T Iveson, J Carmichael, M Alakl, G Gruia, L Awad, P Rougier, Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial The Lancet. ,vol. 355, pp. 1041- 1047 ,(2000) , 10.1016/S0140-6736(00)02034-1
David Cunningham, Yves Humblet, Salvatore Siena, David Khayat, Harry Bleiberg, Armando Santoro, Danny Bets, Matthias Mueser, Andreas Harstrick, Chris Verslype, Ian Chau, Eric Van Cutsem, None, Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. The New England Journal of Medicine. ,vol. 351, pp. 337- 345 ,(2004) , 10.1056/NEJMOA033025